Obesity Advocates Challenge FDA Over Drug Approval Process Disparities

The Obesity Action Coalition and other organizations are urging the FDA to address critical gaps in drug testing, emphasizing the need for specific testing in individuals with obesity to ensure safety and efficacy, as current practices expose this population to unnecessary risks.

Related Keywords

United States ,American ,Angela Fitch ,Joe Nadglowski ,Andy Dean ,American Society For Metabolic ,American College Of Clinical Pharmacology ,Obesity Society ,Obesity Alliance ,Obesity Medicine Association ,Obesity Action Coalition ,American Society ,Bariatric Surgery ,Clinical Pharmacology ,American College ,Obesity ,Health Disparities ,Fda ,Drug Testing ,